We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

12 hedge funds and large institutions have $5.25M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 529 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

98% less funds holding

Funds holding: 546 → 12 (-534)

98% less capital invested

Capital invested by funds: $338M → $5.25M (-$333M)

100% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 529

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
12
Holders Change
-534
Holders Change %
-97.8%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
529
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JCI
Jet Capital Investors
New York
+$2.15M
2
TNB
Thomasville National Bank
Georgia
+$146K

Top Sellers

1
PCM
Pentwater Capital Management
Florida
-$47.7M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$20.6M
3
ACM
Abrams Capital Management
Massachusetts
-$17.1M
4
FCM
Farallon Capital Management
California
-$14.8M
5
BFS
Bard Financial Services
Connecticut
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
326
Parametric Portfolio Associates
Washington
– -$7K -10,595 Closed
BCV
327
Banque Cantonale Vaudoise
Switzerland
– -$6K -10,586 Closed
CCM
328
Condor Capital Management
New Jersey
– -$7K -10,435 Closed
FPCP
329
Fort Point Capital Partners
California
– -$7K -10,347 Closed
PWP
330
Principle Wealth Partners
Connecticut
– -$7K -10,167 Closed
Allianz Asset Management
331
Allianz Asset Management
Germany
– -$7K -10,113 Closed
Northwestern Mutual Wealth Management
332
Northwestern Mutual Wealth Management
Wisconsin
– -$7K -10,041 Closed
Mercer Global Advisors
333
Mercer Global Advisors
Colorado
– -$7K -10,018 Closed
FC
334
Fore Capital
New York
– -$7K -10,000 Closed
TI
335
Telemetry Investments
New York
– -$7K -10,000 Closed
MCM
336
Manchester Capital Management
Vermont
– -$7K -9,796 Closed
CIA
337
Choate Investment Advisors
Massachusetts
– -$6K -9,079 Closed
SO
338
STRS Ohio
Ohio
– -$6K -8,861 Closed
HWA
339
Heritage Wealth Advisors
Virginia
– -$6K -8,424 Closed
PI
340
PEAK6 Investments
Illinois
– -$6K -8,160 Closed
Russell Investments Group
341
Russell Investments Group
United Kingdom
– -$137K -7,657 Closed
MOACM
342
Mutual of America Capital Management
New York
– -$5K -7,537 Closed
CA
343
Clearstead Advisors
Ohio
– -$5K -7,535 Closed
FMII
344
Farmers & Merchants Investments Inc
Nebraska
– -$5K -7,329 Closed
AA
345
Ancora Advisors
Ohio
– -$5K -6,525 Closed
ASN
346
Advisory Services Network
Georgia
– -$4K -6,381 Closed
BBHC
347
Brown Brothers Harriman & Co
New York
– -$4K -5,838 Closed
IFAM
348
Institutional & Family Asset Management
Colorado
– -$4K -5,599 Closed
1IA
349
1834 Investment Advisors
Wisconsin
– -$3K -4,900 Closed
AII
350
AGF Investments Inc
Ontario, Canada
– -$3K -4,895 Closed
12 13
14
15 16

BMY.RT Hedge Fund Activity: Q1 2021 in Review

12 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q1 2021, worth a combined $5.25M — down 98% from $338M a quarter earlier.

Sellers outnumbered buyers: 529 funds closed out of BMY.RT and 2 opened new positions — a net loss of 527 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Jet Capital Investors, adding an estimated $2.15M. The largest seller was Pentwater Capital Management, exiting entirely with an estimated $47.7M sold.

  • 12 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q1 2021, down from 546 in Q4 2020.
  • Funds reported $5.25M of Bristol-Myers Squibb Company Contingent Value Rights stock for Q1 2021, down 98% quarter-over-quarter.
  • 2 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q1 2021 and 529 closed out, a net change of -527 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q1 2021 was Jet Capital Investors, an estimated $2.15M added.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights seller in Q1 2021 was Pentwater Capital Management, an estimated $47.7M sold.

Based on aggregated 13F filings for Q1 2021.